Advertisement

Up 32% in 2022, Is Eli Lilly Stock Still a Buy?

Up 32% in 2022, Is Eli Lilly Stock Still a Buy?

The consumer price index increased 7.7% year over year in October, a solid signal that the inflation rate is now trending in the right direction. The pharma stock Eli Lilly (NYSE: LLY) is chief among these stocks. Let's take a look under the hood at Eli Lilly's fundamentals and valuation to decide.